Share: Facebook Twitter LinkedIn
Activity Provided By:

ACHL

Guideline & Testing Update for Treatment of Invasive Fungal Infections in Hospitalized Patients (Webcast)

Access Activity

Overview / Abstract:

Target Audience:
This educational activity is designed for infectious disease specialists, intensivists, hospitalists, hospital pharmacists, and other clinicians involved in the management of patients with invasive fungal infections.

Statement of Need:
The incidence of invasive fungal infections continues to increase, resulting in significant morbidity and mortality, despite the introduction of expanded treatment options. Clinicians require up-to-date knowledge of advances in testing approaches and novel antifungal agents to guide clinician-decision making and ensure that at-risk patients receive prompt, appropriate therapy.

Learning Objectives:
Upon completion of this activity, participants will be able to:
• Identify patients at risk of invasive fungal infections in critical care and other hospital settings
• Compare and contrast the mechanisms of action, pharmacokinetics, efficacy, and safety of available and emerging antifungal agents
• Apply diagnostic and susceptibility testing for invasive fungal infections to ensure prompt, appropriate antifungal therapy
• Implement strategies to enhance empiric and definitive antifungal therapy for candidemia

Method of Participation:
The participant should complete the preactivity survey, view the webcast, and complete the post-test and evaluation forms. To receive credit, 80% must be achieved on the post-test. A certificate of credit will be immediately available. There is no fee to participate in the activity or for the generation of the certificate.

Expiration

Nov 18, 2015

Discipline(s)

Nurse Practitioner , Pharmacy CPE, Physician CME

Format

Online, Webinar / Webcast / Video

Accreditation

The Academy for Continued Healthcare Learning is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Academy for Continued Healthcare Learning designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The Academy for Continued Healthcare Learning is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

This activity has been approved for a maximum of 1.25 contact hours.
ACPE Universal Activity Number (UAN): 0396-0000-13-129-H01-P
Activity Type: Knowledge

Is This Activity Certified for "Live" Credit?

YES

Presenters / Authors / Faculty

Craig A. Martin, PharmD, BCBS
Clinical Associate Professor, Adjunct
Director of Professional Practice Development
UK College of Pharmacy and UK Healthcare
Lexington, Kentucky

Peter G. Pappas, MD
Professor of Medicine
Director, Mycoses Study Group
Division of Infectious Diseases
Department of Medicine
University of Alabama at Birmingham
Birmingham, Alabama

The Academy for Continued Healthcare Learning (ACHL) requires that the faculty participating in a CME/CE activity disclose all affiliations or other financial relationships (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity. All conflicts of interest have been resolved prior to this CME/CE activity. ACHL also requires participating faculty to disclose when unapproved/unlabeled uses of a product are discussed in a CME/CE activity.

Craig A. Martin, PharmD, BCBS, Type of financial relationship:
Research Grant: Pfizer
Discussion of Off-Label, Investigational, or Experimental Drug Use: Ravuconazole and isavuconazole

Peter G. Pappas, MD, Type of financial relationships:
Grants Recipient/Advisory Board: Astellas Scientific & Medical Affairs, Inc., Merck & Co, Inc., Gilead Sciences, and T2 Biosystems, Inc.
Discussion of Off-Label, Investigational, or Experimental Drug Use: Ravuconazole and isavuconazole

ACHL staff members and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.

Activity Specialities / Related Topics

Primary Care, Internal Medicine, Infectious Disease, Immunology / Immunosuppression, Immunizations / Vaccinations, Hospital-Acquired Infections, Education / Teaching, Contamination & Infection Control, Antibiotics / Anti-Infectives

Sponsors / Supporters / Grant Providers

Sponsored by The Academy for Continued Healthcare Learning

Supported by an educational grant from Astellas Scientific & Medical Affairs, Inc.

Keywords / Search Terms

ACHL antifungal infections, invastive fungal infections, infectious disease, longterm care, intestivists, hopsitalists, pharmacists, pharmacy, hospital setting, candidemia, infectious diseases, candida disease, aspergillus Free CE CME Live CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map